Search for content, post, videos

Idogen reaches formal granting of patent in Japan

Idogen has announced that the Japan Patent Office (“JPO”) has granted the company’s patent application. The patent provides Idogen’s vaccine technology with a broad protection and further strengthens the company’s patent portfolio in an important market. The Japan Patent Office has now
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.